fda bpc-157 compounding safety risks warning unapproved drug concerns Approval Status: Is It Approved for Human Use? FDA Issues Warning: Certain – fda bpc-157 compounding safety risks

It is labeled for laboratory use and research use only

Upcoming Events August 5 1:00 pm to 2:00 pm ET Peptide Compounding on the Rise: Key Pharmacy Considerations Join APhA for a live webinar exploring non-FDA approved compounded peptides and key pharmacy considerations

they show no significant telomere erosion

Mild side effects, like redness at the injection site, can happen but are typically no big deal

CDC Injection Safety Clinical Guidance for Healthcare Providers supports sterile single-use technique and sharps-disposal discipline

OConnor C, White KL, Doncescu N et al (2015) NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor